AxoGen, Inc. Announces Release Date of 2012 Fourth Quarter & Year End Results and Conference Call

Autor: AxoGen, Inc.
Zdroj: Business Wire (English). 02/27/2013.
Abstrakt: AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it will release its financial results for the period ended December 31, 2012, after the close of U.S. financial markets on March 12, 2013. [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje